ConductScience.org, home

Paper26480907

High frequency hearing thresholds and product distortion otoacoustic emissions in cystic fibrosis patients.

Geyer LB and 3 others. Braz J Otorhinolaryngol, 2015. Cited by 14 papers, by iCite.

Cite this record

ConductScience Library. High frequency hearing thresholds and product distortion otoacoustic emissions in cystic fibrosis patients. Papers, record 26480907. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26480907

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
High frequency hearing thresholds and product distortion otoacoustic emissions in cystic fibrosis patients.
PubMed
Journal
Braz J Otorhinolaryngol
PubMed
Year
2015
PubMed
Publication types
Journal Article, Observational Study, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
0.76
iCite
Revised in PubMed
2024-09-03
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Geyer LBLucia Bencke
2Menna Barreto SSSergio Saldanha
3Weigert LLLiese Loureiro
4Teixeira ARAdriane Ribeiro

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AminoglycosidesMajor topic
Anti-Bacterial AgentsMajor topic
Cystic FibrosisMajor topic
Hearing LossMajor topic
Otoacoustic Emissions, SpontaneousMajor topic
Adolescent
Audiometry, Pure-Tone
Case-Control Studies
Child
Cross-Sectional Studies
Female
Humans
Male
Young Adult

Source PubMed

Download CSV of topics

References37

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110526861Effects of chronic tobramycin treatment on distortion product otoacoustic emissions.Ear Hear1999https://conductscience.org/library/papers/10526861PubMed
23606063Cumulative and acute toxicity of repeated high-dose tobramycin treatment in cystic fibrosis.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3606063PubMed
318389279What's new in cystic fibrosis? From treating symptoms to correction of the basic defect.Eur J Pediatr2008https://conductscience.org/library/papers/18389279PubMed
42202080Aminoglycoside-induced ototoxicity.Toxicol Lett1990https://conductscience.org/library/papers/2202080PubMed
53945060Effects of mild and moderate hearing impairments on language, educational, and psychosocial behavior of children.J Speech Hear Disord1986https://conductscience.org/library/papers/3945060PubMed
621760512High-frequency pure-tone audiometry in children: a test-retest reliability study relative to ototoxic criteria.Ear Hear2012https://conductscience.org/library/papers/21760512PubMed
722698459Cystic fibrosis: insight into CFTR pathophysiology and pharmacotherapy.Clin Biochem2012https://conductscience.org/library/papers/22698459PubMed
821265638Aminoglycoside antibiotics cochleotoxicity in paediatric cystic fibrosis (CF) patients: A study using extended high-frequency audiometry and distortion product otoacoustic emissions.Int J Audiol2011https://conductscience.org/library/papers/21265638PubMed
920189661Hearing loss in cystic fibrosis.Int J Pediatr Otorhinolaryngol2010https://conductscience.org/library/papers/20189661PubMed
109056039Comparison of distortion product OAE generation between a patient group requiring frequent gentamicin therapy and control subjects.Br J Audiol1997https://conductscience.org/library/papers/9056039PubMed
1118753950Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.Ear Hear2008https://conductscience.org/library/papers/18753950PubMed
122816859Aminoglycoside ototoxicity in cystic fibrosis. Evaluation by high-frequency audiometry.Am J Dis Child1989https://conductscience.org/library/papers/2816859PubMed
1317308839Auditory monitoring in ototoxicity.Braz J Otorhinolaryngol2006https://conductscience.org/library/papers/17308839PubMed
1422744939The use of high-frequency audiometry increases the diagnosis of asymptomatic hearing loss in pediatric patients treated with cisplatin-based chemotherapy.Pediatr Blood Cancer2013https://conductscience.org/library/papers/22744939PubMed
1512907047The prevalence of neurosensorial hearing loss among cystic fibrosis patients from Hospital de Clínicas de Porto Alegre.Int J Pediatr Otorhinolaryngol2003https://conductscience.org/library/papers/12907047PubMed
163311531Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance.Clin Pharmacokinet1987https://conductscience.org/library/papers/3311531PubMed
1716801404Absence of cochleotoxicity measured by standard and high-frequency pure tone audiometry in a trial of once- versus three-times-daily tobramycin in cystic fibrosis patients.Antimicrob Agents Chemother2006https://conductscience.org/library/papers/16801404PubMed
1817401008Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions.J Clin Oncol2007https://conductscience.org/library/papers/17401008PubMed
191583319High-frequency audiometric monitoring for early detection of aminoglycoside ototoxicity.J Infect Dis1992https://conductscience.org/library/papers/1583319PubMed
2011843723Otoacoustic emissions for monitoring aminoglycoside-induced ototoxicity in children with cystic fibrosis.Arch Otolaryngol Head Neck Surg2002https://conductscience.org/library/papers/11843723PubMed

See all 37 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
38333844Aminoglycoside-induced sensorineural hearing loss in pediatric cystic fibrosis patients: A retrospective cohort study.Heliyon2024https://conductscience.org/library/papers/38333844PubMed
37895824Aminoglycosides-Related Ototoxicity: Mechanisms, Risk Factors, and Prevention in Pediatric Patients.Pharmaceuticals (Basel)2023https://conductscience.org/library/papers/37895824PubMed
37356412A longitudinal study of the peripheral and central auditory pathways in individuals with acute lymphoid leukemia.Clinics (Sao Paulo)2023https://conductscience.org/library/papers/37356412PubMed
34234249Detection of unknown ototoxic adverse drug reactions: an electronic healthcare record-based longitudinal nationwide cohort analysis.Sci Rep2021https://conductscience.org/library/papers/34234249PubMed
33465313Functional Impacts of Aminoglycoside Treatment on Speech Perception and Extended High-Frequency Hearing Loss in a Pediatric Cystic Fibrosis Cohort.Am J Audiol2021https://conductscience.org/library/papers/33465313PubMed
29791559Sequential analysis as a tool for detection of amikacin ototoxicity in the treatment of multidrug-resistant tuberculosis.J Bras Pneumol2018https://conductscience.org/library/papers/29791559PubMed
29471610Ototoxicity: A Challenge in Diagnosis and Treatment.J Audiol Otol2018https://conductscience.org/library/papers/29471610PubMed
28238634The cumulative effects of intravenous antibiotic treatments on hearing in patients with cystic fibrosis.J Cyst Fibros2017https://conductscience.org/library/papers/28238634PubMed
27894912Hearing thresholds at high frequency in patients with cystic fibrosis: a systematic review.Braz J Otorhinolaryngol2017https://conductscience.org/library/papers/27894912PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CFTR1080PubTator's text mininghttps://conductscience.org/library/genes/1080

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26480907

GET https://conductscience.org/api/papers/v1/26480907/references?page=2